United Community Banks (UCB)
(Delayed Data from NYSE)
$29.30 USD
-0.61 (-2.04%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $29.29 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Price, Consensus and EPS Surprise
UCB 29.30 -0.61(-2.04%)
Will UCB be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for UCB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for UCB
Ameris Bancorp (ABCB) Earnings Expected to Grow: Should You Buy?
United Community Banks (UCB) Earnings Expected to Grow: Should You Buy?
UCB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Northrim Bancorp (NRIM) Hikes Quarterly Cash Dividend by 1.6%
Stock Yards Bancorp (SYBT) Hikes Quarterly Cash Dividend by 3.3%
United Community (UCB) Hikes Dividend, Amends Repurchase Plan
Other News for UCB
State Street Corp's Strategic Adjustment in United Community Banks Inc Holdings
United Community Banks Inc (UCB) Trading 3.17% Higher on Oct 15
United Community Banks Inc (UCB) Shares Up 3.03% on Oct 11
UCB Announces a Head-to-Head Study Evaluating BIMZELX? (bimekizumab) versus SKYRIZI? (risankizumab) in Active Psoriatic Arthritis
United Community Banks, Inc. Announces Date for Third Quarter 2024 Earnings Release and Conference Call